14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BMRN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for BioMarin Pharmaceutical Inc.
(Updated on May 03, 2024)

Sell candidate since Apr 30, 2024 Gain 2.08% PDF

The BioMarin Pharmaceutical Inc. stock price fell by -1.62% on the last day (Friday, 3rd May 2024) from $83.80 to $82.44. During the last trading day the stock fluctuated 3.01% from a day low at $82.32 to a day high of $84.80. The price has been going up and down for this period, and there has been a -6.98% loss for the last 2 weeks. Volume has increased on the last day by 434 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $132.17 million.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $80.66 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -2.15% during the next 3 months and, with a 90% probability hold a price between $78.93 and $89.83 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BMRN Signals & Forecast

There are mixed signals in the stock today. The BioMarin Pharmaceutical Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $86.90. On a fall, the stock will find some support from the short-term average at $82.22. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. A buy signal was issued from a pivot bottom point on Tuesday, April 30, 2024, and so far it has risen 2.08%. Further rise is indicated until a new top pivot has been found.

Support, Risk & Stop-loss for BioMarin Pharmaceutical Inc. stock

BioMarin Pharmaceutical Inc. finds support from accumulated volume at $82.17 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.48 between high and low, or 3.01%. For the last week, the stock has had daily average volatility of 3.26%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BMRN) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect BioMarin Pharmaceutical Inc. to open at $83.19, and during the day (based on 14 day Average True Range), to move between $79.92 and $84.96, which gives a possible trading interval of +/-$2.52 (+/-3.06%) up or down from last closing price. If BioMarin Pharmaceutical Inc. takes out the full calculated possible swing range there will be an estimated 6.11% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $82.17 (0.33%) than the resistance at $86.28 (4.66%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is BioMarin Pharmaceutical Inc. stock A Buy?

BioMarin Pharmaceutical Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.619 Sell Candidate Unchanged

Predicted Opening Price for BioMarin Pharmaceutical Inc. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$83.19 ( 0.91%) $82.44

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BMRN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 85.67 3.91 %
R2 84.72 2.76 %
R1 84.13 2.05 %
Current price: 82.44
Support S1 82.24 -0.243 %
S2 81.65 -0.95 %
S3 80.71 -2.10 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 92.22 11.86 %
R2 91.24 10.67 %
R1 86.28 4.66 %
Current price 82.44
Support S1 82.17 -0.328%
S2 80.91 -1.86%
S3 80.76 -2.04%

FAQ

What is the symbol for BioMarin Pharmaceutical Inc. Stock and on which exchange is it traded?
The symbol for BioMarin Pharmaceutical Inc. is BMRN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioMarin Pharmaceutical Inc. Stock?
BioMarin Pharmaceutical Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy BioMarin Pharmaceutical Inc. Stock?
BioMarin Pharmaceutical Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioMarin Pharmaceutical Inc. Stock.

What's the current price of BioMarin Pharmaceutical Inc. Stock?
As of the end of day on the May 03, 2024, the price of an BioMarin Pharmaceutical Inc. (BMRN) share was $82.44.

What is the 52-week high and low for BioMarin Pharmaceutical Inc. Stock?
The 52-week high for BioMarin Pharmaceutical Inc. Stock is $99.55 and the 52-week low is $76.02.

What is the market capitalization of BioMarin Pharmaceutical Inc. Stock?
As of the May 03, 2024, the market capitalization of BioMarin Pharmaceutical Inc. is 15.654B.

When is the next earnings date for BioMarin Pharmaceutical Inc.?
The upcoming earnings date for BioMarin Pharmaceutical Inc. is Jul 29, 2024.
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT